LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.

Nigam, Milan / Hippolyte, Amandine / Dodet, Pauline / Gales, Ana / Maranci, Jean-Baptiste / Al-Youssef, Saba / Leu-Semenescu, Smaranda / Arnulf, Isabelle

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

2021  Volume 18, Issue 1, Page(s) 255–263

Abstract: ... Citation: Nigam M, Hippolyte A, Dodet P, et al. Sleeping through a pandemic: impact of COVID-19-related ... restrictions on narcolepsy and idiopathic hypersomnia. ... on narcolepsy type 1 (NT2), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).: Methods: Participants ...

Abstract Study objectives: To assess the impact of coronavirus disease 2019 (COVID-19)-related restrictions on narcolepsy type 1 (NT2), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
Methods: Participants with NT1, NT2, and IH followed in a university hospital completed an online 78-question survey assessing demographic, clinical, and occupational features of the population during the first COVID-19-related lockdown.
Results: A total of 219 of 851 (25.7%) respondents of the survey reported a mean increase of 1.2 ± 1.9 hours (
Conclusions: Extended sleep time, circadian delay (in patients with IH), and teleworking resulted in decreased symptoms of central hypersomnias. These findings suggest that people with IH, NT1, and NT2 may benefit from a decrease in social and professional constraints on sleep-wake habits, and support advocacy efforts aimed at facilitating workplace and schedule accommodations for this population.
Citation: Nigam M, Hippolyte A, Dodet P, et al. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.
MeSH term(s) COVID-19 ; Communicable Disease Control ; Disorders of Excessive Somnolence/epidemiology ; Humans ; Idiopathic Hypersomnia/complications ; Idiopathic Hypersomnia/drug therapy ; Idiopathic Hypersomnia/epidemiology ; Narcolepsy/drug therapy ; Narcolepsy/epidemiology ; Pandemics ; SARS-CoV-2 ; Sleep
Language English
Publishing date 2021-07-03
Publishing country United States
Document type Journal Article
ZDB-ID 2397213-0
ISSN 1550-9397 ; 1550-9389
ISSN (online) 1550-9397
ISSN 1550-9389
DOI 10.5664/jcsm.9556
Shelf mark
Zs.A 6590: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top